Log in

Relevant bibliographies by topics / Coronary heart disease Molecular aspects / Journal articles

To see the other types of publications on this topic, follow the link: Coronary heart disease Molecular aspects.

Journal articles on the topic 'Coronary heart disease Molecular aspects'

Author: Grafiati

Published: 4 June 2021

Last updated: 1 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Coronary heart disease Molecular aspects.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Pries, Axel R., Wolfgang M. Kuebler, and Helmut Habazettl. "Coronary Microcirculation in Ischemic Heart Disease." Current Pharmaceutical Design 24, no. 25 (November 8, 2018): 2893–99. http://dx.doi.org/10.2174/1381612824666180625142341.

Full text

Abstract:

Background: Ischemic heart disease has long been considered to be exlusively caused by stenosis or occlusion. However, the coronary microcirculation too may play an important role in ischemic conditions. Also, the crucial role of microvessels in not only regulating blood flow on a local level but also mediating vascular permeability or inflammatory responses has been recognized. Objective: To review important physiological and pathophysiological mechanisms of coronary microcirculatory control with focus on heterogeneity of local perfusion, microvascular permeability and inflammation. Method: S

APA, Harvard, Vancouver, ISO, and other styles

2

Cavarretta, Elena, and Giacomo Frati. "MicroRNAs in Coronary Heart Disease: Ready to Enter the Clinical Arena?" BioMed Research International 2016 (2016): 1–10. http://dx.doi.org/10.1155/2016/2150763.

Full text

Abstract:

Coronary artery disease (CAD) and its complication remain the leading cause of mortality in industrialized countries despite great advances in terms of diagnosis, prognosis, and treatment options. MicroRNAs (miRNAs), small noncoding RNAs, act as posttranscriptional gene expression modulators and have been implicated as key regulators in several physiological and pathological processes linked to CAD. Circulating miRNAs have been evaluated as promising novel biomarkers of CAD, acute coronary syndromes, and acute myocardial infarction, with prognostic implications. Several challenges related to t

APA, Harvard, Vancouver, ISO, and other styles

3

Santosa Putra, Iwan Cahyo, and William Kamarullah. "Diving deep into chelation therapy for coronary artery disease: a review." International Journal of Basic & Clinical Pharmacology 8, no. 12 (November 25, 2019): 2769. http://dx.doi.org/10.18203/2319-2003.ijbcp20195295.

Full text

Abstract:

Chelation therapy is still a mainstay therapy when it comes to dealing with heavy metal intoxication. The ability of various chelators to bind metal and other chemical molecules led to the idea whether chelation therapy can be used as an alternative therapy to enchain calcium element that is known to be present in the atherosclerotic plaque. Various studies have been conducted, one of which is a large trial to assess chelation therapy study to show in case ethylenediaminetetraacetic acid (EDTA) chelator can be proven by evidence-based in managing coronary heart disease. Despite the favorable r

APA, Harvard, Vancouver, ISO, and other styles

4

Khaw, Kay-Tee. "Epidemiological aspects of ageing." Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences 352, no. 1363 (December 29, 1997): 1829–35. http://dx.doi.org/10.1098/rstb.1997.0168.

Full text

Abstract:

A major societal challenge is to improve quality of life and prevent or reduce disability and dependency in an ageing population. Increasing age is associated with increasing risk of disability and loss of independence, due to functional impairments such as loss of mobility, hearing and vision; a major issue must be how far disability can be prevented. Ageing is associated with loss of bone tissue, reduction in muscle mass, reduced respiratory function, decline in cognitive function, rise in blood pressure and macular degeneration which predispose to disabling conditions such as osteoporosis,

APA, Harvard, Vancouver, ISO, and other styles

5

Malekmohammad, Khojasteh, Robert D. E. Sewell, and Mahmoud Rafieian-Kopaei. "Antioxidants and Atherosclerosis: Mechanistic Aspects." Biomolecules 9, no. 8 (July 25, 2019): 301. http://dx.doi.org/10.3390/biom9080301.

Full text

Abstract:

Atherosclerosis is a chronic inflammatory disease which is a major cause of coronary heart disease and stroke in humans. It is characterized by intimal plaques and cholesterol accumulation in arterial walls. The side effects of currently prescribed synthetic drugs and their high cost in the treatment of atherosclerosis has prompted the use of alternative herbal medicines, dietary supplements, and antioxidants associated with fewer adverse effects for the treatment of atherosclerosis. This article aims to present the activity mechanisms of antioxidants on atherosclerosis along with a review of

APA, Harvard, Vancouver, ISO, and other styles

6

Simmonds, Steven J., Ilona Cuijpers, Stephane Heymans, and Elizabeth A. V. Jones. "Cellular and Molecular Differences between HFpEF and HFrEF: A Step Ahead in an Improved Pathological Understanding." Cells 9, no. 1 (January 18, 2020): 242. http://dx.doi.org/10.3390/cells9010242.

Full text

Abstract:

Heart failure (HF) is the most rapidly growing cardiovascular health burden worldwide. HF can be classified into three groups based on the percentage of the ejection fraction (EF): heart failure with reduced EF (HFrEF), heart failure with mid-range—also called mildly reduced EF— (HFmrEF), and heart failure with preserved ejection fraction (HFpEF). HFmrEF can progress into either HFrEF or HFpEF, but its phenotype is dominated by coronary artery disease, as in HFrEF. HFrEF and HFpEF present with differences in both the development and progression of the disease secondary to changes at the cellul

APA, Harvard, Vancouver, ISO, and other styles

7

Golukhova, E. Z., O. I. Gromova, R. A. Shomahov, N. I. Bulaeva, and L. A. Bockeria. "Monogenec Arrhythmic Syndromes: From Molecular and Genetic Aspects to Bedside." Acta Naturae 8, no. 2 (June 15, 2016): 62–74. http://dx.doi.org/10.32607/20758251-2016-8-2-62-74.

Full text

Abstract:

The abrupt cessation of effective cardiac function that is generally due to heart rhythm disorders can cause sudden and unexpected death at any age and is referred to as a syndrome called sudden cardiac death (SCD). Annually, about 400,000 cases of SCD occur in the United States alone. Less than 5% of the resuscitation techniques are effective. The prevalence of SCD in a population rises with age according to the prevalence of coronary artery disease, which is the most common cause of sudden cardiac arrest. However, there is a peak in SCD incidence for the age below 5 years, which is equal to

APA, Harvard, Vancouver, ISO, and other styles

8

Bastos, Marcelo B., Maarten P. van Wiechen, and Nicolas M. Van Mieghem. "PulseCath iVAC2L: next-generation pulsatile mechanical circulatory support." Future Cardiology 16, no. 2 (March 2020): 103–12. http://dx.doi.org/10.2217/fca-2019-0060.

Full text

Abstract:

Contemporary state of the art percutaneous coronary intervention techniques offer treatment strategies and solutions to an increasing number of patients with heart failure and complex coronary artery disease. Percutaneous mechanical circulatory support is intended to alleviate the mechanical and energetic workload imposed to a failing ventricle by reducing left ventricle pressures and volumes and potentially also increasing coronary blood flow. The PulseCath iVAC2L is a transaortic left ventricular assist device that applies a pneumatic driving system to produce pulsatile forward flow. Herein,

APA, Harvard, Vancouver, ISO, and other styles

9

Ventegodt, Søren, Efrat Merrick, and Joav Merrick. "Clinical Holistic Medicine: The Dean Ornish Program (“Opening the Heart”) in Cardiovascular Disease." Scientific World JOURNAL 6 (2006): 1977–84. http://dx.doi.org/10.1100/tsw.2006.330.

Full text

Abstract:

Dean Ornish of the Preventive Medicine Research Institute in Sausalito, California has created an intensive holistic treatment for coronary heart patients with improved diet (low fat, whole foods, plant based), exercise, stress management, and social support that has proven to be efficient. In this paper, we analyze the rationale behind his cure in relation to contemporary holistic medical theory. In spite of a complex treatment program, the principles seem to be simple and in accordance with holistic medical theories, like the Antonovsky concept of rehabilitating the sense of coherence and th

APA, Harvard, Vancouver, ISO, and other styles

10

Shi, Qi, Kuo Gao, Huihui Zhao, Juan Wang, Xing Zhai, Peng Lu, Jianxin Chen, and Wei Wang. "Phenomics Research on Coronary Heart Disease Based on Human Phenotype Ontology." BioMed Research International 2014 (2014): 1–16. http://dx.doi.org/10.1155/2014/240284.

Full text

Abstract:

The characteristics of holistic, dynamics, complexity, and spatial and temporal features enable “Omics” and theories of TCM to interlink with each other. HPO, namely, “characterization,” can be understood as a sorting and generalization of the manifestations shown by people with diseases on the basis of the phenomics. Syndrome is the overall “manifestation” of human body pathological and physiological changes expressed by four diagnostic methods’ information. The four diagnostic methods’ data could be the most objective and direct manifestations of human body under morbid conditions. In this a

APA, Harvard, Vancouver, ISO, and other styles

11

Bambauer, Rolf, Carolin Bambauer, Boris Lehmann, Reinhard Latza, and Ralf Schiel. "LDL-Apheresis: Technical and Clinical Aspects." Scientific World Journal 2012 (2012): 1–19. http://dx.doi.org/10.1100/2012/314283.

Full text

Abstract:

The prognosis of patients suffering from severe hyperlipidemia, sometimes combined with elevated lipoprotein (a) levels, and coronary heart disease refractory to diet and lipid-lowering drugs is poor. For such patients, regular treatment with low-density lipoprotein (LDL) apheresis is the therapeutic option. Today, there are five different LDL-apheresis systems available: cascade filtration or lipid filtration, immunoadsorption, heparin-induced LDL precipitation, dextran sulfate LDL adsorption, and the LDL hemoperfusion. There is a strong correlation between hyperlipidemia and atherosclerosis.

APA, Harvard, Vancouver, ISO, and other styles

12

Nikolaev, K. Yu, K. I. Bondareva, A. Ya Kovaleva, and G. I. Lifshic. "Peculiarities of hypoglycaemic therapy in acute coronary syndrome in patients with type 2 diabetes mellitus." Patologiya krovoobrashcheniya i kardiokhirurgiya 25, no. 2 (June 28, 2021): 27. http://dx.doi.org/10.21688/1681-3472-2021-2-27-37.

Full text

Abstract:

<p>This study assessed the features of the course of acute coronary syndrome in patients with diabetic neuropathy. Additionally, the role of antihyperglycaemic therapy as a cardio protection factor in this syndrome was determined by analysing the available literature data and clinical guidelines. Various antihyperglycaemic drug groups demonstrate possible molecular mechanisms of protection against ischemic cardiomyocytes. Cardiovascular disease treatment for patients with type 2 diabetes mellitus is rapidly developing. However, many aspects, including the exact mechanisms of the cardio p

APA, Harvard, Vancouver, ISO, and other styles

13

Amin, Mohammad Nurul, Shafayet Ahmed Siddiqui, Md Ibrahim, Md Lukman Hakim, Md Salim Ahammed, Asma Kabir, and Farhana Sultana. "Inflammatory cytokines in the pathogenesis of cardiovascular disease and cancer." SAGE Open Medicine 8 (January 2020): 205031212096575. http://dx.doi.org/10.1177/2050312120965752.

Full text

Abstract:

Inflammatory cytokines are highly inducible small glycoproteins or regulatory proteins of low molecular weight secreted by different cell types. They regulate intercellular communication and mediate a number of physiological functions in the human immune system. Numerous prospective studies report that inflammatory cytokines strongly predict coronary artery disease, myocardial infarction, heart failure and other adverse cardiac events. Inflammatory cascade is believed to be a causative factor in the development of atherosclerotic process. Several aspects of atherogenesis are accelerated by cyt

APA, Harvard, Vancouver, ISO, and other styles

14

De La Grandmaison, G. Lorin, and M. Durigon. "Sudden Adult Death: A Medico-Legal Series of 77 Cases between 1995 and 2000." Medicine, Science and the Law 42, no. 3 (July 2002): 225–32. http://dx.doi.org/10.1177/002580240204200306.

Full text

Abstract:

Among all the autopsies performed between 1995 and 2000 in our Department, 77 adult cases of sudden death were selected. Sex, age, place of death, circumstances of death, causes of death and heart weight were reported from these 77 post-mortem records. A complete forensic autopsy was performed in every case. Sudden death occurred more frequently in males at rest. Strenuous activity was rarely involved in sudden death and 72.7% of the cases died from cardiovascular disease, mainly coronary atherosclerosis. Non-cardiac causes were dominated by pulmonary and neurological diseases. Cardiomegaly wa

APA, Harvard, Vancouver, ISO, and other styles

15

Lata Kanyal Butola, Anjali Vaaga, Neelam Gusain, and Karuna Kachhwa. "Aspects of dietary fibre in health and diseases." International Journal of Research in Pharmaceutical Sciences 11, SPL4 (December 21, 2020): 1581–86. http://dx.doi.org/10.26452/ijrps.v11ispl4.4341.

Full text

Abstract:

Dietary fibre is the name collectively given to the indigestible carbohydrates present in foods. These carbohydrates consist of cellulose, gum, pectin and mucilage. Enzymes of gastro-intestinal tracts in humans do not digest these fibres. Plants are the only source of dietary fibre. It is found in grains, vegetables and fruits. Dietary fibre helps to keep the digestive system healthy, and it is vital in reducing the risk of diseases such as coronary heart disease, diabetes, diverticulosis, haemorrhoids and intestinal cancer. Undigested fibres enter the large intestine where bacteria ferments t

APA, Harvard, Vancouver, ISO, and other styles

16

Khan, Johra, Prashanta Kumar Deb, Somi Priya, Karla Damián Medina, Rajlakshmi Devi, Sanjay G. Walode, and Mithun Rudrapal. "Dietary Flavonoids: Cardioprotective Potential with Antioxidant Effects and Their Pharmacokinetic, Toxicological and Therapeutic Concerns." Molecules 26, no. 13 (June 30, 2021): 4021. http://dx.doi.org/10.3390/molecules26134021.

Full text

Abstract:

Flavonoids comprise a large group of structurally diverse polyphenolic compounds of plant origin and are abundantly found in human diet such as fruits, vegetables, grains, tea, dairy products, red wine, etc. Major classes of flavonoids include flavonols, flavones, flavanones, flavanols, anthocyanidins, isoflavones, and chalcones. Owing to their potential health benefits and medicinal significance, flavonoids are now considered as an indispensable component in a variety of medicinal, pharmaceutical, nutraceutical, and cosmetic preparations. Moreover, flavonoids play a significant role in preven

APA, Harvard, Vancouver, ISO, and other styles

17

Goetzl, Edward J., Markus Graeler, Mei-Chuan Huang, and Geetha Shankar. "Lysophospholipid Growth Factors and Their G Protein-Coupled Receptors in Immunity, Coronary Artery Disease, and Cancer." Scientific World JOURNAL 2 (2002): 324–38. http://dx.doi.org/10.1100/tsw.2002.124.

Full text

Abstract:

The physiological lysophospholipids (LPLs), exemplified by lysophosphatidic acid (LPA) and sphingosine 1-phosphate (S1P), are omnific mediators of normal cellular proliferation, survival, and functions. Although both LPA and S1P attain micromolar concentrations in many biological fluids, numerous aspects of their biosynthesis, transport, and metabolic degradation are unknown. Eight members of a new subfamily of G protein-coupled LPA/S1P receptors, originally termed Edg Rs, bind either LPA or S1P with high affinity and transduce a series of growth-related and/or cytoskeleton-based functional re

APA, Harvard, Vancouver, ISO, and other styles

18

Fortini, Francesca, Francesco Vieceli Dalla Sega, Luisa Marracino, Paolo Severi, Claudio Rapezzi, Paola Rizzo, and Roberto Ferrari. "Well-Known and Novel Players in Endothelial Dysfunction: Updates on a Notch(ed) Landscape." Biomedicines 9, no. 8 (August 11, 2021): 997. http://dx.doi.org/10.3390/biomedicines9080997.

Full text

Abstract:

Endothelial dysfunction characterizes every aspect of the so-called cardiovascular continuum, a series of events ranging from hypertension to the development of atherosclerosis and, finally, to coronary heart disease, thrombus formation, myocardial infarction, and heart failure. Endothelial dysfunction is the main prognostic factor for the progression of vascular disorders, which responds to drug intervention and lifestyle changes. Virtually all of the drugs used to prevent cardiovascular disorders, such as long-used and new antilipidemic agents and inhibitors of angiotensin enzyme (ACEi), exe

APA, Harvard, Vancouver, ISO, and other styles

19

Rohatgi, Anand, Marit Westerterp, Arnold von Eckardstein, Alan Remaley, and Kerry-Anne Rye. "HDL in the 21st Century: A Multifunctional Roadmap for Future HDL Research." Circulation 143, no. 23 (June 8, 2021): 2293–309. http://dx.doi.org/10.1161/circulationaha.120.044221.

Full text

Abstract:

Low high-density lipoprotein cholesterol (HDL-C) characterizes an atherogenic dyslipidemia that reflects adverse lifestyle choices, impaired metabolism, and increased cardiovascular risk. Low HDL-C is also associated with increased risk of inflammatory disorders, malignancy, diabetes, and other diseases. This epidemiologic evidence has not translated to raising HDL-C as a viable therapeutic target, partly because HDL-C does not reflect high-density lipoprotein (HDL) function. Mendelian randomization analyses that have found no evidence of a causal relationship between HDL-C levels and cardiova

APA, Harvard, Vancouver, ISO, and other styles

20

Coates, Alison Mary, Samantha Morgillo, Catherine Yandell, Andrew Scholey, Jonathan David Buckley, Kathryn Ann Dyer, and Alison Marie Hill. "Effect of a 12-Week Almond-Enriched Diet on Biomarkers of Cognitive Performance, Mood, and Cardiometabolic Health in Older Overweight Adults." Nutrients 12, no. 4 (April 23, 2020): 1180. http://dx.doi.org/10.3390/nu12041180.

Full text

Abstract:

Long term nut consumption is associated with reduced risk of coronary heart disease and better cognitive function. This study examined supplementing habitual diets with almonds or carbohydrate-rich snack foods (providing 15% energy) on biomarkers of cardiovascular and metabolic health, mood and cognitive performance. Participants (overweight/obese, 50–80 years) were randomised to an almond-enriched diet (AED) or isocaloric nut-free diet (NFD) for 12 weeks. Body weight, blood lipids, glucose, insulin, blood pressure (BP), arterial stiffness, cell adhesions molecules, C reactive protein (CRP), m

APA, Harvard, Vancouver, ISO, and other styles

21

Kumar, Shashank, and Abhay K. Pandey. "Chemistry and Biological Activities of Flavonoids: An Overview." Scientific World Journal 2013 (2013): 1–16. http://dx.doi.org/10.1155/2013/162750.

Full text

Abstract:

There has been increasing interest in the research on flavonoids from plant sources because of their versatile health benefits reported in various epidemiological studies. Since flavonoids are directly associated with human dietary ingredients and health, there is need to evaluate structure and function relationship. The bioavailability, metabolism, and biological activity of flavonoids depend upon the configuration, total number of hydroxyl groups, and substitution of functional groups about their nuclear structure. Fruits and vegetables are the main dietary sources of flavonoids for humans,

APA, Harvard, Vancouver, ISO, and other styles

22

Hidirova, L. D., D. A. Yakhontov, S. A. Zenin, and V. N. Maximov. "Genetic markers of atrial fibrillation in patients with hypertension in combination with non-cardiac diseases." Patologiya krovoobrashcheniya i kardiokhirurgiya 23, no. 1 (July 9, 2019): 83. http://dx.doi.org/10.21688/1681-3472-2019-1-83.

Full text

Abstract:

<p><strong>Letter to the editor:</strong></p><p>The world medical community has categorised atrial fibrillation (AF) as one of the three cardiovascular ‘epidemics of the 21st century’, along with chronic heart failure and diabetes mellitus [1]. In recent years, the prevalence of AF has increasing steadily. However, the exact cause for the increase in the incidence of AF<br />cannot be explained only by the increase in life expectancy, prevalence of cardiac valve disease or prevalence of myocardial infarction [2].</p><p>Although AF occurs in indiv

APA, Harvard, Vancouver, ISO, and other styles

23

Hidirova, L. D., D. A. Yakhontov, S. A. Zenin, and V. N. Maximov. "Genetic markers of atrial fibrillation in patients with hypertension in combination with non-cardiac diseases." Patologiya krovoobrashcheniya i kardiokhirurgiya 23, no. 1 (July 9, 2019): 83. http://dx.doi.org/10.21688/1681-3472-2019-1-83-85.

Full text

Abstract:

<p><strong>Letter to the editor:</strong></p><p>The world medical community has categorised atrial fibrillation (AF) as one of the three cardiovascular ‘epidemics of the 21st century’, along with chronic heart failure and diabetes mellitus [1]. In recent years, the prevalence of AF has increasing steadily. However, the exact cause for the increase in the incidence of AF<br />cannot be explained only by the increase in life expectancy, prevalence of cardiac valve disease or prevalence of myocardial infarction [2].</p><p>Although AF occurs in indiv

APA, Harvard, Vancouver, ISO, and other styles

24

Kringlen, E. "Psychosocial aspects of coronary heart disease." Acta Psychiatrica Scandinavica 74, no. 3 (September 1986): 225–37. http://dx.doi.org/10.1111/j.1600-0447.1986.tb06238.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Seraganian, Peter. "Behavioural aspects of coronary heart disease." Canadian Psychology/Psychologie canadienne 26, no. 2 (April 1985): 113–20. http://dx.doi.org/10.1037/h0080026.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Chen, Zheng-Wei, Cheng-Hsuan Tsai, Chien-Ting Pan, Chia-Hung Chou, Che-Wei Liao, Chi-Sheng Hung, Vin-Cent Wu, and Yen-Hung Lin. "Endothelial Dysfunction in Primary Aldosteronism." International Journal of Molecular Sciences 20, no. 20 (October 21, 2019): 5214. http://dx.doi.org/10.3390/ijms20205214.

Full text

Abstract:

Primary aldosteronism (PA) is characterized by excess production of aldosterone from the adrenal glands and is the most common and treatable cause of secondary hypertension. Aldosterone is a mineralocorticoid hormone that participates in the regulation of electrolyte balance, blood pressure, and tissue remodeling. The excess of aldosterone caused by PA results in an increase in cardiovascular and cerebrovascular complications, including coronary artery disease, myocardial infarction, stroke, transient ischemic attack, and even arrhythmia and heart failure. Endothelial dysfunction is a well-est

APA, Harvard, Vancouver, ISO, and other styles

27

Agewall, Stefan. "Some Aspects of Preventing Coronary Heart Disease." Angiology 63, no. 1 (May 8, 2011): 17–23. http://dx.doi.org/10.1177/0003319711407060.

Full text

Abstract:

Coronary heart disease (CHD) is the leading cause of mortality in the industrialized world and that might also soon be the case in other parts of the world. There are several easily measured and potentially modifiable risk factors that account for a substantial proportion of the risk of CHD. The effect of risk factors interventions appears to be consistent in both genders, across different geographic regions, and by all ethnic groups, suggesting that approaches to prevention can be based on similar principles worldwide. Optimal target levels for serum cholesterol and blood pressure are not yet

APA, Harvard, Vancouver, ISO, and other styles

28

Chen, Li-Ru, and Kuo-Hu Chen. "Utilization of Isoflavones in Soybeans for Women with Menopausal Syndrome: An Overview." International Journal of Molecular Sciences 22, no. 6 (March 22, 2021): 3212. http://dx.doi.org/10.3390/ijms22063212.

Full text

Abstract:

Based on their nutrient composition, soybeans and related foods have been considered to be nutritious and healthy for humans. Particularly, the biological activity and subsequent benefits of soy products may be associated with the presence of isoflavone in soybeans. As an alternative treatment for menopause-related symptoms, isoflavone has gained much popularity for postmenopausal women who have concerns related to undergoing hormone replacement therapy. However, current research has still not reached a consensus on the effects of isoflavone on humans. This overview is a summary of the current

APA, Harvard, Vancouver, ISO, and other styles

29

Blaxter, K. L., and A. J. F. Webster. "Animal production and food: real problems and paranoia." Animal Science 53, no. 3 (December 1991): 261–69. http://dx.doi.org/10.1017/s0003356100020250.

Full text

Abstract:

AbstractThe scientific and technological expansion of British agriculture between the mid 1930s and mid 1980s can be attributed primarily to the provision of favourable and stable prices and only secondly to government support of research and development. These conditions have changed. Most government-funded research in agriculture is now directed to the new biological sciences, molecular biology and transgenics. It is uncertain whether those at the frontiers of biotechnology are aware of the limits and constraints placed on animal production. Equally, it is uncertain whether the commercial su

APA, Harvard, Vancouver, ISO, and other styles

30

Scott, C. D., and J. H. Dark. "Coronary artery disease after heart transplantation: clinical aspects." Heart 68, no. 9 (September 1, 1992): 255–56. http://dx.doi.org/10.1136/hrt.68.9.255.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Korzh, O. M. "CURRENT ASPECTS OF CORONARY HEART DISEASE DIAGNOSIS AND TREATMENT." International Medical Journal, no. 1 (March 5, 2020): 5–10. http://dx.doi.org/10.37436/2308-5274-2020-1-1.

Full text

Abstract:

Among the cardiovascular diseases associated with atherosclerosis, chronic coronary heart disease, including angina, is the most common form. It is the myocardium lesion that develops as a result of an imbalance between the coronary circulation and metabolic needs of heart muscle. The presence of angina symptoms often indicates a pronounced narrowing of one or more coronary arteries, but also occurs in non−obstructive arterial impairment and even in normal coronary arteries. Factors of functional damage to the coronary arteries are spasm, temporary platelet aggregation and intravascular thromb

APA, Harvard, Vancouver, ISO, and other styles

32

GALTON, D. J. "Molecular genetics of coronary heart disease." European Journal of Clinical Investigation 18, no. 3 (June 1988): 219–25. http://dx.doi.org/10.1111/j.1365-2362.1988.tb01249.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Cambien, François. "1.C.6 New genetic aspects of coronary heart disease." Atherosclerosis 134, no. 1-2 (October 1997): 6. http://dx.doi.org/10.1016/s0021-9150(97)88138-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Delva, P. "Magnesium and coronary heart disease." Molecular Aspects of Medicine 24, no. 1-3 (February 6, 2003): 63–78. http://dx.doi.org/10.1016/s0098-2997(02)00092-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Karamermer, Yusuf, and Jolien W. Roos-Hesselink. "Coronary heart disease and pregnancy." Future Cardiology 3, no. 5 (September 2007): 559–67. http://dx.doi.org/10.2217/14796678.3.5.559.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Cambien, François. "Genetics and coronary heart disease." Future Cardiology 1, no. 1 (January 2005): 17–27. http://dx.doi.org/10.1517/14796678.1.1.17.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Thorogood, Margaret. "Vegetarianism, coronary disease risk factors and coronary heart disease." Current Opinion in Lipidology 5, no. 1 (February 1994): 17–21. http://dx.doi.org/10.1097/00041433-199402000-00004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Hansen, Ole, and Bengt W. Johansson. "Epidemiologic Aspects of Coronary Heart Disease in Malmö, Sweden, 1935–1988." American Journal of Epidemiology 133, no. 7 (April 1, 1991): 721–33. http://dx.doi.org/10.1093/oxfordjournals.aje.a115947.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Marasini, B., M. Massarotti, and R. Cossutta. "Scleroderma Heart Disease." International Journal of Immunopathology and Pharmacology 18, no. 4 (October 2005): 609–14. http://dx.doi.org/10.1177/039463200501800401.

Full text

Abstract:

Heart disease is a frequent and often severe feature of systemic sclerosis (scleroderma). Cardiomyopathy, with ventricular diastolic dysfunction and arrhythmias, is the most important form, since it is associated with a very poor prognosis. The current challenge is to define its pattern and identify individuals at risk, but evaluation in vivo may be hard to perform. The aim of this review is to provide an update on the clinical aspects of scleroderma heart disease and the early pivotal role that coronary microcirculation dysfunction plays in its development. A discussion of the diagnostic tool

APA, Harvard, Vancouver, ISO, and other styles

40

Vega, Gloria Lena, and Cesare Sirtori. "Dyslipidemia and coronary heart disease." Current Opinion in Lipidology 7, no. 4 (August 1996): 179–82. http://dx.doi.org/10.1097/00041433-199608000-00001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Garrison, Robert J., Millicent W. Higgins, and William B. Kannel. "Obesity and coronary heart disease." Current Opinion in Lipidology 7, no. 4 (August 1996): 199–202. http://dx.doi.org/10.1097/00041433-199608000-00005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Verhoef, Petra, Meir J. Stampfer, and Eric B. Rimm. "Folate and coronary heart disease." Current Opinion in Lipidology 9, no. 1 (February 1998): 17–22. http://dx.doi.org/10.1097/00041433-199802000-00005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Mackness, Michael I., Bharti Mackness, Paul N. Durrington, Alan M. Fogelman, Judith Berliner, Aldons J. Lusis, Mohamad Navab, Diana Shih, and Gregg C. Fonarow. "Paraoxonase and coronary heart disease." Current Opinion in Lipidology 9, no. 4 (August 1998): 319–24. http://dx.doi.org/10.1097/00041433-199808000-00006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Rissanen, Tiina, Sari Voutilainen, Kristhna Nyyssönen, and Jukka T. Salonen. "Lycopene, Atherosclerosis, and Coronary Heart Disease." Experimental Biology and Medicine 227, no. 10 (November 2002): 900–907. http://dx.doi.org/10.1177/153537020222701010.

Full text

Abstract:

Diets rich in fruits and vegetables containing carotenoids have been of interest because of their potential health benefit against chronic diseases such as cardiovascular diseases (CVD) and cancer. Interest particularly in lycopene is growing rapidly following the recent publication of epidemiological studies that have associated high lycopene levels with reductions in CVD incidence. Two studies were conducted. In the first one, we examined the role of lycopene as a risk-lowering factor with regard to acute coronary events and stroke in the prospective Kuopio Ischemic Heart Disease Risk Factor

APA, Harvard, Vancouver, ISO, and other styles

45

HARRAP, S. "The genetics of coronary heart disease." Journal of Molecular and Cellular Cardiology 24, no. 11 (November 1992): iv. http://dx.doi.org/10.1016/0022-2828(92)93108-v.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Kim, J. Q., J. Song, Y. B. Park, and S. H. Hong. "Molecular bases of coronary heart disease in Koreans." Journal of Korean Medical Science 13, no. 1 (1998): 1. http://dx.doi.org/10.3346/jkms.1998.13.1.1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Deeb, S., A. Failor, B. G. Brown, J. D. Brunzell, J. J. Albers, and A. G. Motulsky. "Molecular Genetics of Apolipoproteins and Coronary Heart Disease." Cold Spring Harbor Symposia on Quantitative Biology 51 (January 1, 1986): 403–9. http://dx.doi.org/10.1101/sqb.1986.051.01.048.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

POLONSKAYA, IRINA I., and VERA V. SERGEYEVA. "MEDICAL AND SOCIAL ASPECTS OF REHABILITATION FOR CORONARY HEART DISEASE AFTER CORONARY ARTERY BYPASS GRAFTING." Bulletin of Contemporary Clinical Medicine 11, no. 6 (December 2018): 68–73. http://dx.doi.org/10.20969/vskm.2018.11(6).68-73.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Amin, Muhammad, Larra Fredrika, and Delvi Duwi Kartika. "Pengalaman dan Gangguan Aktivitas Seksualitas Klien Penyakit Jantung Koroner." Jurnal Kesmas Asclepius 1, no. 2 (December 24, 2019): 186–95. http://dx.doi.org/10.31539/jka.v1i2.967.

Full text

Abstract:

This study aims to determine how the experience of sexual activity disorders in clients with coronary heart disease in Dr. M. Yunus Bengkulu. This type of research used in this research is qualitative, with the phenomenological method. This study resulted in four (4) themes, namely: aspects of knowledge about coronary heart disease, aspects of treatment, aspects of sexual activity disorders in clients with coronary heart disease, emotional aspects. The results showed that sexual activity disorders in coronary heart patients were lack of appetite, stimulation, orgasm, and dyspareunia. In conclu

APA, Harvard, Vancouver, ISO, and other styles

50

Adlercreutz, Herman, Satu-Maarit Heinonen, and José Penalvo-Garcia. "Phytoestrogens, cancer and coronary heart disease." BioFactors 22, no. 1-4 (2004): 229–36. http://dx.doi.org/10.1002/biof.5520220146.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!